Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India,” tweeted Union Health Minister,Mansukh Mandaviya today.Johnson and Johnson Pvt Ltd has applied on Friday for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine in India.“Now India has 5 EUA vaccines. And this will further boost nation's collective fight against Covid-19,” tweet further informed. The EUA submission is based on topline efficacy and safety data from the Phase III ENSEMBLE clinical trial, which demonstrated that company's single-shot vaccine was 85 per cent effective in preventing severe disease across all regions studied.A Johnson and Johnson India spokesperson in a statement further informed that the EUA submission further showed protection against COVID-19 related hospitalisation and death, beginning 28 days after vaccination.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!